Literature DB >> 22935863

Etiology of community-acquired pneumonia in hospitalized children in northern Taiwan.

Chih-Jung Chen1, Pen-Yi Lin, Ming-Han Tsai, Chung-Guei Huang, Kuo-Chien Tsao, Kin-Sun Wong, Luan-Yin Chang, Cheng-Hsun Chiu, Tzou-Yien Lin, Yhu-Chering Huang.   

Abstract

BACKGROUND: Pneumonia is the leading reason for hospitalization in children. The heptavalent pneumococcal conjugate vaccine was introduced in Taiwan in October 2005. There has been no comprehensive study of the etiology of childhood community-acquired pneumonia (CAP), either in the pre- or postpneumococcal conjugate vaccine era, in Taiwan.
METHODS: From August 2001 to July 2002, consecutive children admitted to a teaching hospital with radiologically confirmed CAP were prospectively enrolled. The following were considered indicative of infection when positive: blood or pleural effusion bacterial culture or urinary Streptococcus pneumoniae antigen test (Binax NOW), direct immunofluorescent antigen test for Chlamydia species and viruses, virus isolation and identification and viral, mycoplasmal or chlamydial serologic tests.
RESULTS: A total of 209 children were included, and 102 children (48.8%) were male. Patients' ages ranged from 7 months to 16 years with a median of 4 years and 3 months. The combined tests identified at least 1 etiologic agent in 85.6% of all cases, including typical bacterial pathogens in 88 cases (42.1%; 86 S. pneumoniae, 1 methicillin-resistant Staphylococcus aureus and 1 Mycobacterium tuberculosis), Mycoplasma pneumoniae in 77 cases (36.8%), Chlamydia species in 24 cases (11.5%), viral etiology in 86 cases (41.1%) and mixed viral-bacterial infections in 69 cases (33%). Children with S. pneumoniae infection were significantly younger than those with Mycoplasma pneumoniae infection (P = 0.0055) or unknown etiology (P = 0.0140).
CONCLUSION: S. pneumoniae, Mycoplasma pneumoniae and viruses were equally common etiologic agents of childhood CAP in Taiwan. Frequent coinfection increased the difficulty of both predicting the responsible organisms and choosing empiric antibiotics for the management of pediatric CAP.

Entities:  

Mesh:

Year:  2012        PMID: 22935863     DOI: 10.1097/INF.0b013e31826eb5a7

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  14 in total

Review 1.  The co-pathogenesis of influenza viruses with bacteria in the lung.

Authors:  Jonathan A McCullers
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

2.  Effects of bacterial and viral co-infections of mycoplasma pneumoniae pneumonia in children: analysis report from Beijing Children's Hospital between 2010 and 2014.

Authors:  Qing Song; Bao-Ping Xu; Kun-Ling Shen
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management.

Authors:  Lin Tong; Shumin Huang; Chen Zheng; Yuanyuan Zhang; Zhimin Chen
Journal:  J Clin Med       Date:  2022-05-17       Impact factor: 4.964

4.  Characteristics and etiology of hospitalized pediatric community-acquired pneumonia in Taiwan.

Authors:  Hsin Chi; Yhu-Chering Huang; Ching-Chuan Liu; Kuang-Yi Chang; Yi-Chuan Huang; Hsiao-Chuan Lin; Luan-Yin Chang; Yu-Huai Ho; Kuo-Chien Tsao; Jung-Jung Mu; Li-Min Huang; Yu-Chia Hsieh
Journal:  J Formos Med Assoc       Date:  2020-07-15       Impact factor: 3.282

5.  Impact and clinical profiles of Mycoplasma pneumoniae co-detection in childhood community-acquired pneumonia.

Authors:  Meng-Chuan Zhao; Le Wang; Fang-Zhou Qiu; Li Zhao; Wei-Wei Guo; Shuo Yang; Zhi-Shan Feng; Gui-Xia Li
Journal:  BMC Infect Dis       Date:  2019-10-11       Impact factor: 3.090

6.  Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study.

Authors:  Matthew P Crotty; Shelby Meyers; Nicholas Hampton; Stephanie Bledsoe; David J Ritchie; Richard S Buller; Gregory A Storch; Scott T Micek; Marin H Kollef
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

7.  Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship.

Authors:  Matthew P Crotty; Shelby Meyers; Nicholas Hampton; Stephanie Bledsoe; David J Ritchie; Richard S Buller; Gregory A Storch; Marin H Kollef; Scott T Micek
Journal:  Crit Care       Date:  2015-11-18       Impact factor: 9.097

8.  Impact of Epstein-Barr virus coinfection in Mycoplasma pneumoniae pneumonia.

Authors:  Yingchun Xu; Shuxian Li; Jinling Liu; Junfen Zhou; Fang Jin; Xiaoyang Chen; Yingshuo Wang; Yuan Jiang; Zhimin Chen
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

Review 9.  Review of Non-Bacterial Infections in Respiratory Medicine: Viral Pneumonia.

Authors:  José María Galván; Olga Rajas; Javier Aspa
Journal:  Arch Bronconeumol       Date:  2015-05-07       Impact factor: 4.872

10.  Etiology of community-acquired pneumonia in 1500 hospitalized children.

Authors:  Hao Oumei; Wang Xuefeng; Liu Jianping; Shen Kunling; Ma Rong; Cui Zhenze; Deng Li; Yan Huimin; Wang Lining; Liu Zhaolan; Li Xinmin; Xu Hua; Jiang Zhiyan; Li Yanning; Huang Yan; Zhang Baoqing; Feng Xiaochun; He Chunhui; Jiang Yonghong; Zhao Xue; Wei Wei; Wang Zi
Journal:  J Med Virol       Date:  2017-11-09       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.